Biosimilars Blog
RF 360


Insightful. Precise. Skilled.

Nichole Gifford at World Biosimilar Congress USA 2017

Intellectual Property - Recent Developments and Implications


May 23, 2017 — May 24, 2017

Rothwell Figg partner Nichole Gifford will present at the World Biosimilar Congress USA 2017 being held May 23-24, 2017, in San Diego, California. Ms. Gifford will present on "Intellectual Property – Recent Developments and Implications," and will cover, among other topics:

  • Should the notice requirement delay commercial marketing after FDA approval? The Supreme Court will consider the timing of 180-day notice provision.
  • Can you opt out of the “patent dance”? The Federal Circuit says the BPCIA is not mandatory. Will the Supreme Court agree?
  • An alternative approach: IPRs at the U.S. Patent Office.

For additional information, or to register for the event, please visit the conference website.